Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2021 Publisher: Neon Healthcare Limited, Mill Studio Business Centre, Crane Mead, Ware, Hertfordshire, SG12 9PY, UK
Pharmacotherapeutic group: Antipsychotics, butyrophenone derivatives
ATC code: N05AD07
Benperidol is a potent neuroleptic of the butyrophenone series with general properties similar to those of haloperidol.
After administration of benperidol (2 mg tablets PO) to volunteers, the following values have been reported:
Cmax 4.1 ± 1.7 µg/l, Tmax 2.9 ± 1.8 h, AUC(0-24) 39.8 ± 9.4 µg.h/l.
After repeated administration of 3 and 12 mg benperidol to patients, plasma levels of 10 and 30 µg/l respectively have been reported.
No relevant information additional to that contained elsewhere in the Summary of Product Characteristics.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
